11.62
price up icon0.26%   0.03
after-market 시간 외 거래: 11.50 -0.12 -1.03%
loading
전일 마감가:
$11.59
열려 있는:
$11.63
하루 거래량:
1.08M
Relative Volume:
0.55
시가총액:
$989.56M
수익:
$65,400
순이익/손실:
$-46.34M
주가수익비율:
-12.63
EPS:
-0.92
순현금흐름:
$-38.74M
1주 성능:
-22.33%
1개월 성능:
-7.85%
6개월 성능:
+42.05%
1년 성능:
+181.36%
1일 변동 폭
Value
$11.34
$11.73
1주일 범위
Value
$11.34
$12.98
52주 변동 폭
Value
$3.61
$17.43

CorMedix Inc Stock (CRMD) Company Profile

Name
명칭
CorMedix Inc
Name
전화
908-517-9500
Name
주소
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Name
직원
14
Name
트위터
Name
다음 수익 날짜
2025-03-25
Name
최신 SEC 제출 서류
Name
CRMD's Discussions on Twitter

CRMD을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CRMD
CorMedix Inc
11.62 989.56M 65,400 -46.34M -38.74M -0.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

CorMedix Inc Stock (CRMD) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-07 개시 Leerink Partners Outperform
2025-01-13 개시 D. Boral Capital Buy
2024-08-26 개시 Rodman & Renshaw Buy
2023-08-10 개시 RBC Capital Mkts Outperform
2021-02-17 개시 Needham Buy
2020-09-29 개시 JMP Securities Mkt Outperform
2020-09-21 개시 Truist Buy
2019-12-18 개시 B. Riley FBR Buy
2019-03-26 재확인 H.C. Wainwright Buy
2018-12-06 개시 ROTH Capital Buy
2017-09-25 재확인 H.C. Wainwright Buy
2017-08-10 재확인 Rodman & Renshaw Buy
2017-05-05 재확인 Rodman & Renshaw Buy
2016-11-11 재확인 FBR & Co. Outperform
2016-03-17 재확인 FBR Capital Outperform
2016-03-03 개시 FBR Capital Outperform
2015-11-16 재확인 ROTH Capital Neutral
2015-10-29 재확인 ROTH Capital Neutral
2015-05-06 다운그레이드 ROTH Capital Buy → Neutral
2014-12-08 재확인 ROTH Capital Buy
2011-10-03 다운그레이드 Maxim Group Buy → Hold
모두보기

CorMedix Inc 주식(CRMD)의 최신 뉴스

pulisher
Jun 18, 2025

Despite shrinking by US$64m in the past week, CorMedix (NASDAQ:CRMD) shareholders are still up 366% over 3 years - simplywall.st

Jun 18, 2025
pulisher
Jun 13, 2025

CorMedix stock rises after earnings, revenue beat - MSN

Jun 13, 2025
pulisher
Jun 11, 2025

CorMedix stock soars to 52-week high, hits $15.33 By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

CorMedix stock soars to 52-week high, hits $15.33 - Investing.com Australia

Jun 11, 2025
pulisher
Jun 09, 2025

Long Term Trading Analysis for (CRMD) - news.stocktradersdaily.com

Jun 09, 2025
pulisher
Jun 07, 2025

Cormedix anticipates Q2 revenue at high end of $23M-$31M range with inpatient growth accelerating - MSN

Jun 07, 2025
pulisher
Jun 05, 2025

CorMedix at Jefferies Healthcare: Strategic Expansion and Financial Growth By Investing.com - Investing.com Canada

Jun 05, 2025
pulisher
Jun 05, 2025

CorMedix at Jefferies Healthcare: Strategic Expansion and Financial Growth - Investing.com Australia

Jun 05, 2025
pulisher
Jun 05, 2025

CorMedix stock rises as Q1 earnings and revenue surpass estimates By Investing.com - Investing.com Nigeria

Jun 05, 2025
pulisher
Jun 05, 2025

CorMedix: DefenCath In Exponential Growth Phase With Robust Market Position - Seeking Alpha

Jun 05, 2025
pulisher
Jun 04, 2025

CorMedix:Exceeding Expectations (NASDAQ:CRMD) - Seeking Alpha

Jun 04, 2025
pulisher
May 30, 2025

CorMedix Inc. to Present at Jefferies Global Healthcare Conference on June 5, 2025 - Nasdaq

May 30, 2025
pulisher
May 30, 2025

CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference - The Manila Times

May 30, 2025
pulisher
May 30, 2025

CorMedix Brings Latest Therapeutic Developments to Jefferies Healthcare Conference 2025 - Stock Titan

May 30, 2025
pulisher
May 28, 2025

(CRMD) Trading Advice - news.stocktradersdaily.com

May 28, 2025
pulisher
May 23, 2025

CorMedix Inc. (CRMD) Stock Analysis: Unveiling a 37.30% Potential Upside in Healthcare Biotechnology - DirectorsTalk Interviews

May 23, 2025
pulisher
May 21, 2025

CorMedix at RBC Capital Markets: Strategic Expansion and Growth - Investing.com Australia

May 21, 2025
pulisher
May 21, 2025

CorMedix at RBC Capital Markets: Strategic Expansion and Growth By Investing.com - Investing.com India

May 21, 2025
pulisher
May 15, 2025

CorMedix Inc. to Participate in the RBC Global Healthcare Conference - The Manila Times

May 15, 2025
pulisher
May 15, 2025

CorMedix Inc. to Participate in RBC Capital Markets Global Healthcare Conference on May 21, 2025 - Nasdaq

May 15, 2025
pulisher
May 15, 2025

Leading Biopharma CorMedix Set for Key Presentation at RBC Healthcare Conference Next Week - Stock Titan

May 15, 2025
pulisher
May 10, 2025

CorMedix Inc. Makes NYSE MKT Section 610(b) Public Announcement - ACCESS Newswire

May 10, 2025
pulisher
May 09, 2025

Surging Earnings Estimates Signal Upside for CorMedix (CRMD) Stock - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Market Highlights: CorMedix Inc (CRMD) Ends on a High Note at 12.03 - DWinneX

May 09, 2025
pulisher
May 09, 2025

CorMedix Inc. Just Recorded A 22% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

CorMedix Inc. (CRMD): Among Billionaire Paul Singer’s Stock Picks with Huge Upside Potential - Insider Monkey

May 09, 2025
pulisher
May 08, 2025

Cormedix (CRMD) Receives a Buy from RBC Capital - The Globe and Mail

May 08, 2025
pulisher
May 08, 2025

CorMedix at Citizens JMP: Strategic Growth and Market Expansion By Investing.com - Investing.com Nigeria

May 08, 2025
pulisher
May 08, 2025

CorMedix at Citizens JMP: Strategic Growth and Market Expansion - Investing.com

May 08, 2025
pulisher
May 08, 2025

CorMedix Inc. (NASDAQ:CRMD) Q1 2025 Earnings Call Transcript - Insider Monkey

May 08, 2025
pulisher
May 08, 2025

Analysts Just Shipped A Substantial Upgrade To Their CorMedix Inc. (NASDAQ:CRMD) Estimates - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

CorMedix Inc. Reports Strong Q1 Earnings and Positive Outlook - MSN

May 08, 2025
pulisher
May 08, 2025

CorMedix (CRMD) Surpasses Q1 Earnings and Revenue Estimates - MSN

May 08, 2025
pulisher
May 07, 2025

(CRMD) Investment Analysis - news.stocktradersdaily.com

May 07, 2025
pulisher
May 07, 2025

Earnings call transcript: CorMedix Q1 2025 results beat expectations, stock rises - Investing.com Nigeria

May 07, 2025
pulisher
May 07, 2025

Cormedix Inc (CRMD) Q1 2025 Earnings Call Highlights: Record Profitability and Strategic Growth ... By GuruFocus - Investing.com Canada

May 07, 2025
pulisher
May 07, 2025

CorMedix Inc. Reports Strong Q1 2025 Results - TipRanks

May 07, 2025
pulisher
May 07, 2025

Earnings call transcript: CorMedix Q1 2025 results beat expectations, stock rises By Investing.com - Investing.com South Africa

May 07, 2025
pulisher
May 06, 2025

CorMedix: Q1 Earnings Snapshot - Norwalk Hour

May 06, 2025
pulisher
May 06, 2025

CorMedix Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 06, 2025
pulisher
May 06, 2025

CRMD Price Target Increased as Positive Momentum Builds | CRMD S - GuruFocus

May 06, 2025
pulisher
May 06, 2025

CorMedix Shares Soar After Q1 Earnings, Revenue Beat Consensus - MarketScreener

May 06, 2025
pulisher
May 06, 2025

CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025 - The Globe and Mail

May 06, 2025
pulisher
May 06, 2025

Cormedix Inc (CRMD) Q1 2025 Earnings: EPS of $0.32 Beats Estimat - GuruFocus

May 06, 2025
pulisher
May 06, 2025

CorMedix (CRMD) Surpasses Revenue and EPS Expectations in Q1 - GuruFocus

May 06, 2025
pulisher
May 06, 2025

CRMD Price Target Increased as Positive Momentum Builds | CRMD Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

CorMedix Inc. Revises Sales Guidance for the First Half of 2025 - marketscreener.com

May 06, 2025
pulisher
May 06, 2025

CorMedix (CRMD) Surges on Strong Q1 Earnings - GuruFocus

May 06, 2025
pulisher
May 06, 2025

CorMedix Inc (NASDAQ: CRMD): Hidden Gems In A Time Of Volatility - Stocksregister

May 06, 2025
pulisher
May 06, 2025

CRMD Stock Rating and Price Target Maintained by Analyst | CRMD - GuruFocus

May 06, 2025

CorMedix Inc (CRMD) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

CorMedix Inc 주식 (CRMD) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Todisco Joseph
Chief Executive Officer
Apr 01 '25
Option Exercise
3.38
59,170
199,995
530,721
Mistry Erin
EVP, Chief Commercial Officer
Oct 31 '24
Buy
9.99
1,500
14,985
52,011
Hurlburt Elizabeth
EVP
Nov 14 '24
Option Exercise
4.48
140,027
627,727
185,424
Hurlburt Elizabeth
EVP
Nov 14 '24
Sale
11.18
140,027
1,565,670
45,397
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
자본화:     |  볼륨(24시간):